The Prospects of Phyto-Nanoparticle-Based Anti-Respiratory Virus Agents: A Review

Infections caused by viral agents create major public impairments to well-being, especially given the fact that the appearance of opposing viruses and the undesirable outcomes linked to their extended exploits keep on slowing down the implementation of successful antivirus agent therapy. These have, in turn, contributed to the need for developing safer and more effective advantages over traditional antiviral drugs. Currently, nanomaterials have surfaced as new vaccines because of their unique physicochemical properties. Phyto-nanotechnology offers novel antiviral therapies a motivating opportunity. This reduces the level of metal ions into phyto-nanoparticles, which in essence strike a wide range of viral targets and thus reduce the risk of developing resistance compared to traditional antiviral agents. In essence, this reduces the phyto-materials into nanoparticulate form, which has the ability to hit a huge spectrum of virus targets while also lowering the danger of antiviral resistance associated with traditional antiviral drugs. The current study emphasizes the creation of nanoparticles from natural products and their usage in the treatment of a variety of viral illnesses, including respiratory viral infections.